I am still very on the fence on this since the Adcom. I hope we all make money when the decision arrives
MarkyBoy212
vorige week
A new buy rating and 2 maintained buys very nice
A new buy rating and 2 maintained buys very nice, hoping this gets approval after earnings and award
ByronKS
vorige week
Capricor earnings report
See the Capricor Therapeutics earnings report below. Good luck! 🤞🏼🍀
https://web.quartr.com/link/companies/5913/events/732825/report?rp=0&documentId=4012432
MarkyBoy212
2 weken geleden
Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology
Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology
TerraNova23
2 weken geleden
Anyone else think this will fail?
According to Adam Feuerstein, Capricor faces two major risks:
Weak Clinical Evidence: The FDA may consider Deramiocel's efficacy data insufficient for approval.
Public Pressure on the FDA: Capricor's public statements could suggest concerns about its chances of approval.
And there is still the 3-9 vote from before.
Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress
Prayers
3 maanden geleden
This too (and yh I DO wish I did this in CFD lol)
GGGGM
3 maanden geleden
Thank God for this stock today
$CAPR to the rescue, thank you thus far... NFA
kosen
3 maanden geleden
This pattern looks exactly like yesterday.
If it completely duplicates yesterday’s pattern, we see 11.5 Today???
kosen
3 maanden geleden
What do we think
At a loss now, watching a bit
GGGGM
3 maanden geleden
We going up.. The News is here.. NFA.
$CAPR would soar today as the long awaited news is finally here.
The FDA accepted a major amendment to Capricor's Biologics License Application (BLA) containing 24-month Phase 3 HOPE-3 extension data. Instead of issuing an immediate rejection, the FDA extended the PDUFA target action date to November 22, 2026.
I got in early at $8 and waiting to see above 11 and above..
Note that THIS IS NOT A FINANCIAL ADVICE... NFA
SKM2086
3 maanden geleden
PT - $54
I'm going with a conservative $25-30. We're on the right track now. Definitely close to making permanent moves upwards.
https://uk.investing.com/news/stock-market-news/oppenheimer-upgrades-capricor-stock-rating-on-regulatory-update-93CH-4846076
MarkyBoy212
3 maanden geleden
Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA
Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA nice news guys
Hazlaw1234
3 maanden geleden
$CAPR feels like one to watch very closely today 👀
The official PDUFA target date is tomorrow, Saturday 22 August, but with that falling on a weekend there’s a very real possibility we hear something from the FDA today instead.
As of now there’s been no decision announced, so I’d expect a lot of eyes on CAPR once the US session gets going and especially into after hours.
Could be a very important day for the stock. Definitely worth keeping notifications on.
NFA
Deze pagina kan door community's gemaakte inhoud bevatten waarvoor Trading 212 niet verantwoordelijk is. Doe altijd je eigen onderzoek. Trading 212 is uitsluitend gericht op orderuitvoering. Wij bieden geen beleggingsadvies of portefeuillebeheer.
Vermogen opbouwen is een gewoonte. Automatiseer je groei aan de hand van een pie.
Beleg volgens kant-en-klare pies, of stel je eigen verdeling samen uit duizenden aandelen en ETF's
Meer informatie
Meer informatie
Bekijk de video
Beleg zelfs in de duurste aandelen zoals Google, Amazon en Apple.
Bekijk de video
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
London Stock Exchange
Euronext Lissabon
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
London Stock Exchange
Euronext Lissabon
Bekijk alle handelsinstrumenten
24/7-ondersteuning
Gemiddeld binnen 29 seconden reactie
Begin nu vermogen op te bouwen
Sluit je aan bij 5 miljoen gebruikers
Download de app
Rekening openen
Download de mobiele app
Alle gepresenteerde statistieken zijn wereldwijd. Het aantal klanten vertegenwoordigt klanten die ten minste één account hebben gefinancierd, met uitzondering van klanten van wie de accounts zijn gesloten of gedeactiveerd.
Uitstekend
Beoordeeld met 4,6 / 5 op basis van 108.764 beoordelingen op
Trustpilot
Beoordeeld met 4,6 / 5 op basis van 108.764 beoordelingen op
Trustpilot
Uitgenodigd
Great app very easy to use and lots of…
Great app very easy to use and lots of information. Always upto date with balances and share prices etc.
Uitgenodigd
Smooth experience
The whole thing is smooth and seamless and makes things easy overall.
Uitgenodigd
Really easy to use
Really easy to use. Secure and has the best functionality and features.
Uitgenodigd
Easy to keep up with as informed…
Easy to keep up with as informed everyday or week on interest made . Easy to set up account . No problems .
Uitgenodigd
Easy to operate and work with
Easy to operate and work with. Works very fast and accurately.
Uitgenodigd
How you rate the app
This app is so easy to use and safe really love it.
Uitgenodigd
I opened a cash ISA with them
I opened a cash ISA with them. It was really straightforward to do and interest is added daily. Nice ,easy to use app as well.
Uitgenodigd
Easy to navigate makes investing…
Easy to navigate makes investing interesting, transferred my investments from HL which was very straightforward and now not paying dealing fee’s
Very Happy
Uitgenodigd
App is easy to work
App is easy to work
Good interest rate
Daily interest updates
Uitgenodigd
Very good and informative always stay…
Very good and informative always stay on track with your investments
Uitgenodigd
Reliable
Reliable, trustworthy app to store your money and to build on your existing wealth if you are financially sensible and smart.
Uitgenodigd
Great app
Great app. I would recommend to anyone that’s into investing and making their money grow .
Uitgenodigd
Very easy app to register and use
Very easy app to register and use! Really pleased.
Uitgenodigd
Clear app
Clear app. Easy to invest. Took a whike for money to get in because i did it from bank rather than in app
Uitgenodigd
Very smooth and user friendly
Very smooth and user friendly. Have had zero issues having moved from other brokerages. Will keep using.
Uitgenodigd
Easy to set up and to regular monitor…
Easy to set up and to regular monitor how its performing.
Uitgenodigd
Competitive rates and quick transfers
Very good on money transfers in and out. They take place immediately unlike some other providers.
Very competitive rate on Cash ISA
Uitgenodigd
Customer support is quick and…
Customer support is quick and effective. The app is well organised and easy to use. Would reccommend for anyone even complete beginners.
Uitgenodigd
Easy to set up the Cash ISA
Easy to set up the Cash ISA, funds arrived in account almost immediately. Great to see interest accrual amounts daily.
Uitgenodigd
Reliable
Reliable, Secure. Using it for past 3 years
Dit is een aantal positieve klantbeoordelingen
Onze toekenningen
Veelgestelde vragen
Wat is de aandelenkoers van Capricor Therapeutics?
De huidige prijs van Capricor Therapeutics is $ 7,59.
Wat is de hoogste koers in 52 weken van Capricor Therapeutics?
De hoogste koers in 52 weken voor Capricor Therapeutics is $ 40,37.
Wat is het 52-weeks dieptepunt van Capricor Therapeutics?
Het 52-weeks dieptepunt voor Capricor Therapeutics is $ 2,96.
Wat is de wekelijkse prestatie van Capricor Therapeutics?
In de afgelopen week is de prijs van Capricor Therapeutics veranderd met -20,36%.
Wat is de maandelijkse prestatie van Capricor Therapeutics?
In de afgelopen maand is de prijs van Capricor Therapeutics veranderd met 14,14%.
Wat is de 3-maandsrendement van Capricor Therapeutics?
In de afgelopen drie maanden is de prijs van Capricor Therapeutics met -4,89% veranderd.
Wat is het rendement over 6 maanden van Capricor Therapeutics?
In de afgelopen zes maanden is de prijs van Capricor Therapeutics met -71,81%veranderd.
Wat is de jaarlijkse prestatie van Capricor Therapeutics?
In het afgelopen jaar is de prijs van Capricor Therapeutics veranderd met 31,54%.